RWE in pharma: 5 minutes with…Sreeram Ramagopalan

Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

RWE in Pharma Sreeram Ramagopalan

In this ‘RWE in pharma’ interview series, we are putting various pharma experts in the spotlight and asking them to share their insight on how their industry has traditionally employed real-world evidence (RWE), how they envision this changing over the next few years and what their predictions of the impacts of the highly anticipated US FDA RWE Framework may be. Our expert for this instalment is Sreeram Ramagopalan, Global Head of Real-World Evidence, Market Access, at F. Hoffmann-La Roche (Basel, Switzerland). Please could you introduce yourself, your organization(s) and tell us more about your role?  My name is Sreeram Ramagopalan (everyone calls...

To view this content, please register now for access

It's completely free